Top Gainers & Losers on Feb 26: Tejas Networks, KSB, Mankind Pharma, Tata Motors, Finolex Cables among top gainers

It was another range-bound session for the Indian stock market, as the key averages remained largely unchanged in Thursday’s trade, February 26, with investors assessing the impact of rising crude oil prices amid mounting tensions in the Middle East, even as confidence in global tech stocks improved.

Though the key benchmark indices closed flat, they recovered the majority of the early losses, with the Nifty 50 eventually settling at the 25,496 level, 0.06% higher, while the S&P BSE Sensex also finished the session flat at the 82,248 level.

The broader markets closed mixed, with the Nifty Midcap 100 rallying 0.66%, while the Nifty Smallcap 100 index finished flat. Sectoral performance was mixed, with the Nifty Pharma, Nifty Chemicals, Nifty Oil and Gas, Nifty PSU Bank, and Nifty Auto indices rallying between 0.80% and 1.10%.

On the lower side, the Nifty Media index lost 0.67% of its value, and the Nifty FMCG index shed 0.23%. The recent laggard, Nifty IT, closed flat.

The US stock market rallied overnight as chip major Nvidia delivered strong fiscal fourth-quarter results, fueled by a 75% surge in revenue from its core data center segment.

The key Asian markets closed mixed, with South Korea’s Kospi rising 3.67% and Japan’s Nikkei 225 falling 1.56% amid profit-taking after the index crossed the 59,000 level, led by software-related shares, as investor fears over disruption from artificial intelligence eased and expectations of looser monetary policy strengthened.

Tejas Networks surges on NEC deal; banks, capital goods, and auto stocks shine

Tejas Networks led the gainers’ list, as the stock rallied 17% to 381.40 apiece, marking its biggest intraday jump since April last year, after the company said it had inked an agreement with NEC Corporation to manufacture and supply 5G massive MIMO radios.

The rally also turned the stock’s month-to-date returns positive, reaching 9%. Jammu & Kashmir Bank shares remained higher for the fifth straight session, closing 8% higher at 121 apiece. In reaction to its strong December quarter performance, KSB shares rallied 7.7% to 772 apiece.

Finolex Cables, too, finished the session higher by 6% at 873 apiece, while Transformers & Rectifiers regained strength, surging 5.3% to 311.90 apiece. After a three-day slide, Brainbees Solutions stock rebounded 4.7% to 220 apiece.

Meanwhile, mid- and small-cap IT stocks such as Oracle Financial Services, Newgen Software Technologies, and Birlasoft gained 3.7%, 3.6%, and 3.2%, respectively. In the auto and auto ancillary pack, Tube Investments of India, Eicher Motors, and Tata Motors DVR rallied 4%, 2.7%, and 2.5%, respectively.

Home First Finance slides sharply; Sagility hits 8-month low

On the losing side, Home First Finance shares crashed 6% to 1,177 apiece amid a large block deal, while Sagility shares saw renewed selling pressure, falling 5.54% to 40.38 apiece, the lowest level since June 2025.

Today’s fall has led to a 19% crash in the stock so far in February. Aegis Logistics was another weak performer in trade, with the stock falling 4% to 698.8 apiece. Reliance Infrastructure also saw renewed selling pressure, declining 4% to 94 apiece.

Other stocks such as BLS International Services, Afcons Infrastructure, Nippon Life India AMC, Affle 3i, Poly Medicure, Sapphire Foods India, and MRF closed lower between 3% and 3.8%.

Disclaimer: We advise investors to check with certified experts before making any investment decisions.

Latest

HCLTech, TCS, Infosys: Why are IT stocks falling again?

Fresh pressure on IT shares as demand concerns and foreign selling unsettle investors

Dr Reddy’s jumps nearly 7% as Sensex falls: Why is the pharma stock rising?

Shares of Dr Reddy’s Laboratories surged sharply on Thursday, bucking a weak broader market and emerging as one of the top gainers on the Nifty 50.

Sensex tumbles 650 points: Why is the stock market falling?

Stock markets remained sharply lower in early trade on Thursday as crude oil above $100, global uncertainty and broad-based selling in financial and IT stocks w

Sensex, Nifty sink as crude oil prices reach $100; IndiGo down 2%

The S&P BSE Sensex was down by 625.09 points to 77,891.40, while the NSE Nifty50 lost 173.90 points to 24,204.20 as of 9:26 am. 

Groww shares hit 52-week high: What’s driving the rally and should you buy now?

Groww shares soar to new heights, but brokerages offer mixed advice

Topics

Explained: Why stock markets are rising even as crude oil remains above $100

Benchmark indices rallied in early trade on Monday despite crude oil remaining elevated above $100. The move reflected bargain buying and global AI-led optimism

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr

Watch out Apple and Samsung, OpenAI is making AI smartphone with agentic capabilities

OpenAI is reportedly working with MediaTek and Qualcomm on smartphone processors, aiming to build an AI-first device powered by agent-led experiences.

ICSE, ISC board results to be out this week? Here’s what CISCE official has to say

The Council for the Indian School Certificate Examinations (CISCE) will declare the much-awaited ICSE Class 10 and ISC Class 12 Results 2026 shortly. Officials

Sam Altman says Codex is causing major FOMO so he changing his sleep schedule

Sam Altman says GPT-5.5 in Codex is so good he’s cutting sleep. He has said due to AI he has switched to polyphasic sleep — a schedule involving multiple sh

Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?

Cohance Lifesciences jumped 20% after appointing former Cipla CEO Umang Vohra. Investors are betting his leadership can accelerate growth and transform the comp

30 students suspended at Hansraj College over fest chaos, DUSU calls it undemocratic

Hansraj College has placed around 30 students, including four elected union office-bearers, under interim suspension over alleged misconduct tied to its annual

Decoding the Sun Pharma $11.75 billion deal: Why the pharma stock jumped 7% today?

The stock was trading around Rs 1,739.70 as of 9:46 am, up over 7%, after touching a high of Rs 1,741.85 during the session, reflecting strong investor interest
spot_img

Related Articles

Popular Categories

spot_imgspot_img